Dengue NS1 Rapid Test – EZER™ Antigen Assay
The EZER™ Dengue NS1 Rapid Test is a chromatographic lateral flow immunoassay for the qualitative detection of Dengue NS1 antigen in human whole blood, serum, or plasma. Designed for early-phase screening, this test identifies Dengue virus infections during the first few days of illness-when NS1 antigen levels are highest and IgM/IgG antibodies may still be undetectable. The test covers all four serotypes of Dengue virus (DEN-1, 2, 3, 4) and can be used as a frontline diagnostic tool in clinical laboratories and outbreak settings. With a time-to-result of just 10 minutes and overall agreement of 99.4%, it delivers rapid and confident results to guide early intervention and case management. Each test kit includes a dropper, sample buffer, and cassette-based test device. The result is visualized through red control (C) and test (NS1) lines. A positive Dengue NS1 result indicates active viral antigenemia, typically within the first 1–5 days of symptom onset. This test offers high Dengue NS1-positive detection performance with 97.4% sensitivity and 100% specificity, making it ideal for tropical disease surveillance, emergency diagnostics, and decentralized healthcare settings.
Quote-based, no public pricing. Add to your quote and our specialists put together a proposal with the right documentation, typically within 24 hours.
This kit in detail
- Dengue NS1-targeted – Detects all four dengue serotypes
- Fast results – 10-minute time-to-result for early infection
- High accuracy – 97.4% sensitivity and 100% specificity
- Versatile samples – Works with blood, serum, or plasma
What is in the Dengue NS1 Rapid Test?
Each kit contains:
-
20 EZER™ Dengue NS1 test cassettes
-
20 sterile plastic droppers
-
1 sample buffer bottle
-
1 package insert with instructions
The test detects Dengue NS1 antigen through immunochromatographic analysis. If NS1 is present in the sample, a red line appears in the NS1 test region (T) along with the control (C) line.
EZER™ Dengue NS1 Rapid Test cassette with positive result showing red test and control linesRole of Dengue NS1 in Disease
Dengue NS1 is a non-structural protein secreted into the bloodstream during early Dengue virus infection. Unlike antibodies that take days to appear, NS1 antigen is detectable as early as Day 1 of fever.
Its detection:
-
Aids in early dengue confirmation
-
Facilitates patient triage during outbreaks
-
Allows rapid case differentiation in endemic zones
-
Provides actionable results before seroconversion
Because Dengue NS1-positive results reflect active viremia, this test is particularly effective within the first 1–5 days after symptom onset, before IgM or IgG antibody detection becomes reliable.
About the EZER™ Dengue NS1 Rapid Test
This test is developed by Genesis Biotech and incorporates monoclonal antibodies specific for Dengue NS1, conjugated to colloidal gold particles. The test targets antigens from all four Dengue virus serotypes (DEN-1 to DEN-4).
Performance Summary:
-
Sensitivity: 97.4%
-
Specificity: 100%
-
Overall Agreement: 99.4%
-
Time to Result: 10 minutes
-
LOD for Dengue NS1 (DEN-1 to DEN-4): 3.5×10⁻³ to 6.25×10⁻² mg/mL
No cross-reactivity with:
-
Influenza A/B
-
RSV
-
Adenovirus
-
HIV, HCV, HBV
-
Syphilis or H. pylori
The test is validated against commercial ELISA (EIA) methods and is highly reliable for early dengue detection.
Principle and Workflow
Sample Types:
-
Whole blood (EDTA, citrate, or heparin)
-
Serum or plasma
Test Procedure:
-
Let device and sample reach room temperature
-
Add 30 µL of specimen to the cassette sample well
-
Add 2 drops of buffer
-
Wait 10 minutes before reading
Result Interpretation:
-
Positive: Two red lines (C and NS1)
-
Negative: One red line (C only)
-
Invalid: No control line, retest required
The visual format and 10-minute read time support high-throughput testing in clinical or field conditions.
Clinical Application
The EZER™ Dengue NS1 Rapid Test is intended for:
-
Early diagnosis during acute dengue illness
-
Outbreak response in endemic regions
-
Hospital triage in emergency or pediatric departments
-
Public health screening in high-risk populations
With its fast turnaround and Dengue NS1-positive accuracy, the test empowers healthcare providers to:
-
Start supportive therapy earlier
-
Reduce dengue transmission
-
Improve patient outcomes
-
Differentiate dengue from other febrile illnesses
It is especially useful in regions with co-circulating arboviruses like Zika and Chikungunya.
Datasheets and regulatory documentation
Everything your quality team needs for evaluation and procurement.
Add this kit to your quote
Tell us the platforms and throughput you’re planning for and our specialists will put together a clear proposal with the right documentation, no public pricing, just a considered answer.
